Drug · DIN 02231590
ABELCET
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 31, 2025; first marketed September 25, 1997.
- Drug Identification Number (DIN)
- 02231590
- Company (DIN owner)
- Leadiant Biosciences, Inc.Scarborough, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Intravenous
- Therapeutic class (ATC)
- Amphotericin B J02AA01
- Class
- Human
- Record last updated
- August 5, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMPHOTERICIN B | 5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 20, 2017: NOC 19546New Drug Submission (NDS) · Manufacturer name change
- March 31, 2010: NOC 11199New Drug Submission (NDS) · Manufacturer name change
- December 16, 2002: NOC 189New Drug Submission (NDS) · Manufacturer name change
- October 15, 2002: NOC 197New Drug Submission (NDS) · Manufacturer name change
- June 24, 1997: NOC 3281New Drug Submission (NDS)